Yunnan Botanee Bio-Technology Group Co Ltd (300957) — Cash Flow-to-Debt Ratio
Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥125.55 Million could theoretically repay 0% of its total liabilities (CN¥1.98 Billion) in one year. See 300957 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yunnan Botanee Bio-Technology Group Co Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Yunnan Botanee Bio-Technology Group Co Ltd across 9 annual periods. Also explore how fast is Yunnan Botanee Bio-Technology Group Co L growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Year-by-year debt coverage analysis for Yunnan Botanee Bio-Technology Group Co Ltd. For market capitalisation and broader financial context, see market value of Yunnan Botanee Bio-Technology Group Co L.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | CN¥976.60 Million | CN¥2.04 Billion | ▲ +46.0% |
| 2024 | 0.33x | CN¥694.87 Million | CN¥2.12 Billion | ▼ -19.8% |
| 2023 | 0.41x | CN¥610.44 Million | CN¥1.49 Billion | ▼ -40.6% |
| 2022 | 0.69x | CN¥769.45 Million | CN¥1.12 Billion | ▼ -38.2% |
| 2021 | 1.11x | CN¥1.15 Billion | CN¥1.03 Billion | ▲ +24.5% |
| 2020 | 0.90x | CN¥431.03 Million | CN¥481.52 Million | ▼ -43.9% |
| 2019 | 1.60x | CN¥514.92 Million | CN¥322.82 Million | ▲ +388.7% |
| 2018 | 0.33x | CN¥102.20 Million | CN¥313.11 Million | ▼ -61.4% |
| 2017 | 0.85x | CN¥202.44 Million | CN¥239.40 Million | — |